KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Non-Current Debt (2018 - 2025)

Historic Non-Current Debt for Takeda Pharmaceutical (TAK) over the last 8 years, with Q4 2025 value amounting to $27.7 billion.

  • Takeda Pharmaceutical's Non-Current Debt fell 1035.26% to $27.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $27.7 billion, marking a year-over-year decrease of 1035.26%. This contributed to the annual value of $26.0 billion for FY2025, which is 1611.52% down from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Non-Current Debt of $27.7 billion as of Q4 2025, which was down 1035.26% from $29.5 billion recorded in Q3 2025.
  • Takeda Pharmaceutical's 5-year Non-Current Debt high stood at $43.6 billion for Q1 2021, and its period low was $26.0 billion during Q1 2025.
  • Its 5-year average for Non-Current Debt is $32.1 billion, with a median of $30.5 billion in 2023.
  • Its Non-Current Debt has fluctuated over the past 5 years, first plummeted by 2556.75% in 2022, then soared by 653.13% in 2024.
  • Quarter analysis of 5 years shows Takeda Pharmaceutical's Non-Current Debt stood at $37.2 billion in 2021, then decreased by 25.57% to $27.7 billion in 2022, then grew by 4.83% to $29.0 billion in 2023, then rose by 6.53% to $30.9 billion in 2024, then fell by 10.35% to $27.7 billion in 2025.
  • Its Non-Current Debt was $27.7 billion in Q4 2025, compared to $29.5 billion in Q3 2025 and $28.6 billion in Q2 2025.